Aura Kasih
A new generation of health supplements, packaged in an appealing gummy format, are flooding the market with bold claims, often backed by vague references to "clinical testing" that may not offer the definitive proof consumers expect.
The allure of the gummy vitamin is undeniable, offering a palatable departure from the chalky pills and bitter powders of yesteryear. For many, especially parents seeking to ensure their children receive essential nutrients, the concept of a vitamin in a chewy, fruit-flavored form is a welcome innovation. This shift towards more enjoyable supplement consumption has paved the way for brands like Grüns, which have aggressively leveraged social media to cultivate a devoted following. Their marketing messages frequently echo a similar refrain: "My kids love these," "Tastes better than greens powders," and assurances of being allergen-free, sugar-free, vegan, and complete with daily nutrient requirements.
However, beneath the glossy veneer of influencer endorsements and carefully curated messaging lies a more complex reality. The rise of "science-washing" – the practice of using scientific jargon and superficial evidence to lend an air of credibility to products – is particularly prevalent in the unregulated wellness industry. Consumers are increasingly bombarded with terms like "clinically tested" and "scientifically backed," often accompanied by simplified graphs and endorsements, all designed to create a perception of rigorous scientific validation.
Grüns exemplifies this trend, prominently featuring "clinically-tested" on its website, accompanied by an image of a gummy bear in a petri dish. This imagery, reminiscent of marketing used by other viral greens powder products, aims to evoke a sense of scientific inquiry. Further down, a cartoon mascot, "Dr. Barry," is depicted with scientific terminology such as "12 weeks," "placebo-controlled," "double-blind," and "randomized." While the company states that blood tests were conducted to assess folate and vitamin C levels, showing an increase in participants, the details remain scant. A footnote reveals that the study involved 120 healthy adults aged 23 to 59, but critically, a link to the actual peer-reviewed study is conspicuously absent. This lack of transparency forces consumers to rely solely on the brand’s assertions.
Experts have long raised concerns about the efficacy of gummy vitamins compared to traditional forms like tablets or powders. Factors such as ingredient stability and the potential for degradation over time can impact their effectiveness. Furthermore, many gummy supplements, including Grüns, utilize proprietary blends, meaning the precise quantities of each ingredient are not disclosed, leaving consumers in the dark about what they are actually consuming. The reliance on soluble fiber, while beneficial, without the inclusion of insoluble fiber, also raises questions about the product’s overall digestive support. Moreover, health professionals consistently emphasize that while supplements can be a helpful addition, they are not a substitute for a balanced diet rich in whole vegetables.
The Grüns website does, however, readily provide links to third-party testing certificates for contaminants like pesticides and heavy metals, a stark contrast to the opaque presentation of its own clinical study. This selective transparency suggests a strategic approach to marketing, highlighting areas where verifiable data is available while obscuring less favorable or less compelling evidence.
Further investigation into Grüns’ claims led to Citruslabs, the contract research organization (CRO) that conducted the purported clinical study. Citruslabs’ own website offers a page detailing the Grüns study, albeit with limited additional information. While it presents bullet points outlining the study’s design and methodology, and claims the trial adhered to "rigorous scientific standards," the results are presented in a generalized manner. Phrases like "significant increases" in folate and "clinically shown to boost Vitamin C levels" are used, but there is no mention of improved digestive function or bowel regularity – a claim that has been increasingly associated with these types of products, particularly in targeted advertising towards users of GLP-1 medications.
The absence of a direct link to a published, peer-reviewed study is a significant red flag. While peer review can be an expensive and time-consuming process, its absence for a product making health-related claims raises questions about the study’s scientific rigor and potential for bias. For brands operating in the wellness space, where regulatory oversight is limited, voluntary participation in research can be a powerful tool for building consumer trust. However, this trust is undermined when the foundational research is not readily accessible or verifiable.
The situation highlights a growing trend where "clinical testing" has evolved from a rigorous scientific endeavor into a marketing strategy in itself. CROs like Citruslabs offer a spectrum of services, including genuine clinical trials and consumer perception studies. Consumer perception studies, often relying on self-reported data, ask participants for their subjective opinions on a product’s effectiveness. While these can provide valuable insights into user experience, they are inherently prone to bias and are not equivalent to objective, controlled clinical trials. The marketing materials of many wellness brands, including those listed as clients of Citruslabs, can easily blur the lines between these two types of research, leading consumers to believe they are seeing robust scientific evidence when it may be anecdotal or opinion-based feedback.
Grüns’ own website further illustrates this point. Beneath the claims related to its clinical study, statistics are presented such as "67 percent say their overall health and well-being have improved" and "44 percent report clearer thinking and better focus." Crucially, this data originates not from the clinical trial, but from a post-purchase consumer survey of 3,000 customers. While this is disclosed in a footnote, the proximity of this information to the clinical study results can easily lead consumers to conflate the two, assuming the survey data represents scientifically validated findings.
This blurring of scientific and consumer feedback is a tactic observed in the broader wellness industry. The CEO of Grüns, Chad Janis, has publicly defended the efficacy of gummy vitamins, framing skepticism as a "convenient myth" perpetuated by traditional supplement manufacturers. His arguments often pivot to the consumer survey results, a classic example of employing anecdotal evidence to bolster a product’s claims, a strategy that aligns with what is sometimes termed the "wellness grifter playbook."
The core issue with the Grüns clinical study, as presented, is its limited scope. It demonstrates that consuming the gummies leads to increased folate and vitamin C levels compared to not taking any supplement. However, it fails to address the crucial questions consumers likely have: How do these gummies compare to existing greens powders or traditional multivitamins? And, more specifically for targeted advertising, do they genuinely alleviate constipation or improve digestive regularity? While the gummies contain a significant amount of fiber (6g), this does not guarantee improved bowel function. Individual responses can vary widely based on hydration, diet, and other physiological factors, and the potential for gastrointestinal distress cannot be overlooked. The presented study simply does not provide the answers consumers are seeking.
The consumer experience with Grüns gummies further complicates the narrative. While influencers often rave about the taste, numerous online comments and reviews describe a less appealing reality. The gummies are reportedly firm, with a gritty texture and a chemical or grassy aftertaste, a far cry from the delightful experience implied by many endorsements. This discrepancy between marketing and reality underscores the challenges consumers face in navigating the wellness market, where perceived benefits often outweigh verifiable efficacy.
Ultimately, the "clinically tested" label, when presented in this manner, becomes a tool for implying trustworthiness rather than providing concrete evidence. The unregulated nature of the supplement market necessitates a critical approach from consumers, who must look beyond buzzwords and marketing claims to seek genuine, verifiable scientific backing. The trend of CROs offering a menu of research services, from rigorous clinical trials to subjective consumer surveys, presents an opportunity for brands to enhance their credibility, but also a potential avenue for misleading consumers about the true nature of the evidence supporting their products. The quest for transparency and efficacy in the wellness sector remains an ongoing challenge, demanding a discerning eye from both consumers and regulatory bodies.
Ayu Aulia
